Vaccine against Heamophilus parasuis
AssigneeIntervet Inc.
InventorsAntonius Arnoldus Christiaan Jacobs, Theodora Johanna Van Kasteren-Westerneng, Johanna Jacoba Elisabeth Bijlsma
Life of this patent
Estimating the term…
Abstract
The invention pertains to a serine protease antigen which induces antibodies against a protein having at least 69% sequence identity with the Haemophilus parasuis protein according to SEQ ID No: 1, for use in a prophylactic method to protect a pig against an infection with Haemophilus parasuis by administering a vaccine to the pig, wherein the vaccine comprises the serine protease antigen. The invention also pertains to a vaccine, a method to manufacture such a vaccine and a method to protect a pig against H. parasuis.
Claims7
A method to protect a pig against an infection with Haemophilus parasuis comprising administering to the pig a vaccine that comprises a Haemophilus parasuis serine protease antigen, wherein the antigen consists of the amino acid sequence of SEQ ID NO:
- 2 or the amino acid sequence of SEQ ID NO:
- 1 or the amino acid sequence having at least 69% sequence identity to amino acid residues 1 to 520 of SEQ ID NO:
- 1 and also comprising the amino acid sequence of SEQ ID NO:
- 2.
An immunogenic composition comprising a serine protease antigen wherein the antigen consists of the amino acid sequence of SEQ ID NO:
- 2 and an adjuvant.
Dependencies are inferred from the claim text.